Renal Cell Carcinoma Global Clinical Trials Review, H1, 2014

Date: April 24, 2014
Pages: 215
Price:
US$ 2,500.00 US$ 1,875.00
Offer valid until December 31, 2016!
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: R375CDE50A3EN
Leaflet:

Download PDF Leaflet

Summary

GlobalData's clinical trial report, “Renal Cell Carcinoma Global Clinical Trials Review, H1, 2014' provides data on the Renal Cell Carcinoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Renal Cell Carcinoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Renal Cell Carcinoma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope
  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Introduction
Renal Cell Carcinoma
Report Guidance
Clinical Trials by Region
Clinical Trials and Average Enrollment by Country
Top Five Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Five Countries Contributing to Clinical Trials in Middle East and Africa
Top Five Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by G7 Countries: Proportion of Renal Cell Carcinoma to Oncology Clinical Trials
Clinical Trials by Phase in G7 Countries
Clinical Trials in G7 Countries by Trial Status
Clinical Trials by E7 Countries: Proportion of Renal Cell Carcinoma to Oncology Clinical Trials
Clinical Trials by Phase in E7 Countries
Clinical Trials in E7 Countries by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Clinical Trials by End Point Status
Unaccomplished Trials of Renal Cell Carcinoma
Subjects Recruited Over a Period of Time
Clinical Trials by Sponsor Type
Prominent Sponsors
Top Companies Participating in Renal Cell Carcinoma Therapeutics Clinical Trials
Prominent Drugs
Latest Clinical Trials News on Renal Cell Carcinoma
Apr 16, 2014: Cleveland BioLabs Announces the Successful Completion of a Phase 1 Study of CBL0102
Apr 07, 2014: Curis and Debiopharm Report Preclinical Data for Debio 0932 at AACR Annual Meeting 2014
Dec 05, 2013: Immunicum Reports Positive Phase I/II-Data for the Therapeutic Cancer Vaccine INTUVAX in the Treatment of Kidney Cancer
Nov 07, 2013: Celldex Therapeutics' CDX-1127 Well Tolerated and Demonstrates Anti-Tumor Activity in Phase 1 Dose-Escalation Study
Sep 26, 2013: Combinability of CRLX101 and Avastin Established in Clinical Trial in Renal Cell Carcinoma
Clinical Trial Profiles
Clinical Trial Overview of Top Companies
Pfizer Inc.
Clinical Trial Overview of Pfizer Inc.
Novartis AG
Clinical Trial Overview of Novartis AG
Bayer AG
Clinical Trial Overview of Bayer AG
GlaxoSmithKline plc
Clinical Trial Overview of GlaxoSmithKline plc
F. Hoffmann-La Roche Ltd.
Clinical Trial Overview of F. Hoffmann-La Roche Ltd.
Bristol-Myers Squibb Company
Clinical Trial Overview of Bristol-Myers Squibb Company
AstraZeneca PLC
Clinical Trial Overview of AstraZeneca PLC
Amgen Inc.
Clinical Trial Overview of Amgen Inc.
Eli Lilly and Company
Clinical Trial Overview of Eli Lilly and Company
AVEO Pharmaceuticals, Inc.
Clinical Trial Overview of AVEO Pharmaceuticals, Inc.
Clinical Trial Overview of Top Institutes / Government
National Cancer Institute
Clinical Trial Overview of National Cancer Institute
The University of Texas M. D. Anderson Cancer Center
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center
European Organization for Research and Treatment of Cancer
Clinical Trial Overview of European Organization for Research and Treatment of Cancer
UCLA's Jonsson Comprehensive Cancer Center
Clinical Trial Overview of UCLA's Jonsson Comprehensive Cancer Center
Roswell Park Cancer Institute
Clinical Trial Overview of Roswell Park Cancer Institute
Case Comprehensive Cancer Center
Clinical Trial Overview of Case Comprehensive Cancer Center
Radboud University
Clinical Trial Overview of Radboud University
The University of Chicago
Clinical Trial Overview of The University of Chicago
Beth Israel Deaconess Medical Center
Clinical Trial Overview of Beth Israel Deaconess Medical Center
Five Key Clinical Profiles
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About GlobalData
Contact Us
Disclaimer
Source

LIST OF TABLES

Renal Cell Carcinoma Therapeutics, Global, Clinical Trials by Region, 2014
Renal Cell Carcinoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014
Renal Cell Carcinoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014
Renal Cell Carcinoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014
Renal Cell Carcinoma Therapeutics Clinical Trials, Europe, Top Five Countries, 2014
Renal Cell Carcinoma Therapeutics Clinical Trials, North America, Top Countries, 2014
Renal Cell Carcinoma Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014
Renal Cell Carcinoma Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014
Proportion of Renal Cell Carcinoma to Oncology Clinical Trials, G7 Countries (%), 2014
Renal Cell Carcinoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2014
Renal Cell Carcinoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014
Proportion of Renal Cell Carcinoma to Oncology Clinical Trials, E7 Countries (%), 2014
Renal Cell Carcinoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2014
Renal Cell Carcinoma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014
Renal Cell Carcinoma Therapeutics, Global, Clinical Trials by Phase, 2014
Renal Cell Carcinoma Therapeutics, Global, Clinical Trials In Progress by Phase 2014
Renal Cell Carcinoma Therapeutics, Global, Clinical Trials by Trial Status, 2014
Renal Cell Carcinoma Therapeutics Clinical Trials, Global, by End Point Status, 2014
Renal Cell Carcinoma Therapeutics, Global, Suspended Clinical Trials, 2014
Renal Cell Carcinoma Therapeutics, Global, Withdrawn Clinical Trials, 2014
Renal Cell Carcinoma Therapeutics, Global, Terminated Clinical Trials, 2014
Renal Cell Carcinoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
Renal Cell Carcinoma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014
Renal Cell Carcinoma Therapeutics Clinical Trials, Global, Key Sponsors, 2014
Renal Cell Carcinoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014
Renal Cell Carcinoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014
Renal Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014
Renal Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014
Renal Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2014
Renal Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014
Renal Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2014
Renal Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2014
Renal Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014
Renal Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2014
Renal Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2014
Renal Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by AVEO Pharmaceuticals, Inc., 2014
Renal Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014
Renal Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2014
Renal Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2014
Renal Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by European Organization for Research and Treatment of Cancer, 2014
Renal Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by UCLA's Jonsson Comprehensive Cancer Center, 2014
Renal Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Roswell Park Cancer Institute, 2014
Renal Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Case Comprehensive Cancer Center, 2014
Renal Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Radboud University, 2014
Renal Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Chicago, 2014
Renal Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Beth Israel Deaconess Medical Center, 2014

LIST OF FIGURES

Renal Cell Carcinoma Therapeutics, Global, Clinical Trials by Region (%), 2014
Renal Cell Carcinoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014
Renal Cell Carcinoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014
Renal Cell Carcinoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014
Renal Cell Carcinoma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014
Renal Cell Carcinoma Therapeutics Clinical Trials, North America, Top Countries (%), 2014
Renal Cell Carcinoma Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014
Renal Cell Carcinoma Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014
Proportion of Renal Cell Carcinoma to Oncology Clinical Trials, G7 Countries (%), 2014
Renal Cell Carcinoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2014
Renal Cell Carcinoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014
Proportion of Renal Cell Carcinoma to Oncology Clinical Trials, E7 Countries (%), 2014
Renal Cell Carcinoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2014
Renal Cell Carcinoma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014
Renal Cell Carcinoma Therapeutics, Global, Clinical Trials by Phase (%), 2014
Renal Cell Carcinoma Therapeutics, Global, Clinical Trials In Progress by Phase, 2014
Renal Cell Carcinoma Therapeutics, Global, Clinical Trials by Trial Status, 2014
Renal Cell Carcinoma Therapeutics Clinical Trials, Global, by End Point Status, 2014
Renal Cell Carcinoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
Renal Cell Carcinoma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014
Renal Cell Carcinoma Therapeutics Clinical Trials, Global, Key Sponsors, 2014
Renal Cell Carcinoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014
Renal Cell Carcinoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014
GlobalData Methodology
Skip to top


Renal Pain Global Clinical Trials Review, H2, 2014 US$ 1,875.00 Jul, 2014 · 64 pages
Renal Cell Carcinoma - Pipeline Review, H2 2016 US$ 2,000.00 Nov, 2016 · 793 pages

Ask Your Question

Renal Cell Carcinoma Global Clinical Trials Review, H1, 2014
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: